UB Paderborn / Katalog / Suche / in CDI

1 – 13 von 13

Sortiert nach

Carrier-free combination for dry powder inhalation of antibiotics in the treatment of lung infections in cystic fibrosis

International journal of pharmaceutics, 2013-07, Vol.451 (1-2), p.112-120

2013

Volltextzugriff (PDF)

Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties

International journal of pharmaceutics, 2012-05, Vol.428 (1-2), p.103-113

2012

Volltextzugriff (PDF)

Formulation and characterization of lipid-coated tobramycin particles for dry powder inhalation

Pharmaceutical research, 2006-05, Vol.23 (5), p.931-940

2006

Volltextzugriff (PDF)

Development of Neutralizing Multimeric Nanobody Constructs Directed against IL-13: From Immunization to Lead Optimization

The Journal of immunology (1950), 2021-11, Vol.207 (10), p.2608-2620

2021

Volltextzugriff (PDF)

New Co-Spray-Dried Tobramycin Nanoparticles-Clarithromycin Inhaled Powder Systems for Lung Infection Therapy in Cystic Fibrosis Patients

Journal of pharmaceutical sciences, 2013-06, Vol.102 (6), p.1836-1846

2013

Volltextzugriff (PDF)

New Respirable and Fast Dissolving Itraconazole Dry Powder Composition for the Treatment of Invasive Pulmonary Aspergillosis

Pharmaceutical research, 2012-10, Vol.29 (10), p.2845-2859

2012

Volltextzugriff (PDF)

Pharmacokinetic evaluation in mice of amorphous itraconazole-based dry powder formulations for inhalation with high bioavailability and extended lung retention

European journal of pharmaceutics and biopharmaceutics, 2014-01, Vol.86 (1), p.46-54

2014

Volltextzugriff (PDF)

In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice

European journal of pharmaceutics and biopharmaceutics, 2012-08, Vol.81 (3), p.627-634

2012

Volltextzugriff (PDF)

New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosis

International journal of nanomedicine, 2012-01, Vol.7 (default), p.5475-5489

2012

Volltextzugriff (PDF)

Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation

European journal of pharmaceutics and biopharmaceutics, 2006-05, Vol.63 (1), p.51-58

2006

Volltextzugriff (PDF)

Optimization and scaling-up of ITZ-based dry powders for inhalation

Journal of drug delivery science and technology, 2017-02, Vol.37, p.147-157

2017

Volltextzugriff (PDF)

In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice

European journal of pharmaceutics and biopharmaceutics, 2012, Vol.81 (3), p.647-654

2012

Volltextzugriff (PDF)

Pharmacoscintigraphic evaluation of lipid dry powder budesonide formulations for inhalation

European journal of pharmaceutics and biopharmaceutics, 2006-08, Vol.64 (1), p.26-32

2006

Volltextzugriff (PDF)

1 – 13 von 13

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(13)

Sprache

Erscheinungsjahr

n.n

Zeitschrift / Serie

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Carrier-free combination for dry powder inhalation of antibiotics in the treatment of lung infections in cystic fibrosis

Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties

Formulation and characterization of lipid-coated tobramycin particles for dry powder inhalation

Development of Neutralizing Multimeric Nanobody Constructs Directed against IL-13: From Immunization to Lead Optimization

New Co-Spray-Dried Tobramycin Nanoparticles-Clarithromycin Inhaled Powder Systems for Lung Infection Therapy in Cystic Fibrosis Patients

New Respirable and Fast Dissolving Itraconazole Dry Powder Composition for the Treatment of Invasive Pulmonary Aspergillosis

Pharmacokinetic evaluation in mice of amorphous itraconazole-based dry powder formulations for inhalation with high bioavailability and extended lung retention

In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice

New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosis

Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation

Optimization and scaling-up of ITZ-based dry powders for inhalation

In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice

Pharmacoscintigraphic evaluation of lipid dry powder budesonide formulations for inhalation

Suchergebnisse filtern